Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Voorberg

Showing results (121-130 of 153) with videos related to

Pageof 16
Sort By:
Haematologica|January 7, 2018
Desmopressin in moderate hemophilia A patients: a treatment worth consideringJanneke I Loomans, Marieke J H A Kruip, Manuel Carcao, et al.
Blood Advances|August 8, 2025
Trp1250, Lys1252 and Arg1367 of ADAMTS13 comprise a hot-spot for anti-CUB domain antibodies in patients with iTTPTim Postmus, Robin Jansen, Paul Kaijen, et al.
Scientific Reports|September 10, 2017
Monitoring storage induced changes in the platelet proteome employing label free quantitative mass spectrometryMaaike Rijkers, Bart L van den Eshof, Pieter F van der Meer, et al.
Platelets|October 3, 2022
Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophagesThijs L J van Osch, Juulke Steuten, Jan Nouta, et al.
Blood|April 18, 2008
Guanine exchange factor RalGDS mediates exocytosis of Weibel-Palade bodies from endothelial cellsMariska G Rondaij, Ruben Bierings, Ellen L van Agtmaal, et al.
Blood Advances|December 18, 2025
Allele-selective Disruption of Pathogenic VWF Variants in Type 2 Von Willebrand Disease using CRISPR/Cas9Isabel Bär, Stijn A Groten, Alastair Barraclough, et al.
Blood|April 4, 2002
Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIIIEdward N van den Brink, Wendy S Bril, Ellen A M Turenhout, et al.
Blood Advances|September 10, 2021
Plasma and rhADAMTS13 reduce trauma-induced organ failure by restoring the ADAMTS13-VWF axisDerek J B Kleinveld, Derek D G Simons, Charlotte Dekimpe, et al.
Journal of Thrombosis and Haemostasis : JTH|October 29, 2025
A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and summary of product characteristics: communication from the ISTH SSC working group on gene therapyCaroline M A Mussert, Wolfgang Miesbach, Pratima Chowdary, et al.
Haematologica|March 24, 2018
Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQJohana Hrdinová, Fabian C Verbij, Paul H P Kaijen, et al.
Pageof 16

Showing results (121-130 of 153) with videos related to

Sort By:
Pageof 16
Haematologica|January 7, 2018
Desmopressin in moderate hemophilia A patients: a treatment worth consideringJanneke I Loomans, Marieke J H A Kruip, Manuel Carcao, et al.
Blood Advances|August 8, 2025
Trp1250, Lys1252 and Arg1367 of ADAMTS13 comprise a hot-spot for anti-CUB domain antibodies in patients with iTTPTim Postmus, Robin Jansen, Paul Kaijen, et al.
Scientific Reports|September 10, 2017
Monitoring storage induced changes in the platelet proteome employing label free quantitative mass spectrometryMaaike Rijkers, Bart L van den Eshof, Pieter F van der Meer, et al.
Platelets|October 3, 2022
Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophagesThijs L J van Osch, Juulke Steuten, Jan Nouta, et al.
Blood|April 18, 2008
Guanine exchange factor RalGDS mediates exocytosis of Weibel-Palade bodies from endothelial cellsMariska G Rondaij, Ruben Bierings, Ellen L van Agtmaal, et al.
Blood Advances|December 18, 2025
Allele-selective Disruption of Pathogenic VWF Variants in Type 2 Von Willebrand Disease using CRISPR/Cas9Isabel Bär, Stijn A Groten, Alastair Barraclough, et al.
Blood|April 4, 2002
Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIIIEdward N van den Brink, Wendy S Bril, Ellen A M Turenhout, et al.
Blood Advances|September 10, 2021
Plasma and rhADAMTS13 reduce trauma-induced organ failure by restoring the ADAMTS13-VWF axisDerek J B Kleinveld, Derek D G Simons, Charlotte Dekimpe, et al.
Journal of Thrombosis and Haemostasis : JTH|October 29, 2025
A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and summary of product characteristics: communication from the ISTH SSC working group on gene therapyCaroline M A Mussert, Wolfgang Miesbach, Pratima Chowdary, et al.
Haematologica|March 24, 2018
Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQJohana Hrdinová, Fabian C Verbij, Paul H P Kaijen, et al.
Pageof 16